Telos Capital Management Inc. Has $2.01 Million Stock Position in Zoetis Inc. $ZTS

Telos Capital Management Inc. lowered its position in Zoetis Inc. (NYSE:ZTS) by 70.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,867 shares of the company’s stock after selling 30,695 shares during the period. Telos Capital Management Inc.’s holdings in Zoetis were worth $2,007,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. Brighton Jones LLC increased its position in Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after buying an additional 2,978 shares during the last quarter. Mutual Advisors LLC grew its position in shares of Zoetis by 48.2% in the first quarter. Mutual Advisors LLC now owns 5,470 shares of the company’s stock valued at $839,000 after purchasing an additional 1,779 shares in the last quarter. Capital Investment Advisory Services LLC grew its position in shares of Zoetis by 37.4% in the first quarter. Capital Investment Advisory Services LLC now owns 2,501 shares of the company’s stock valued at $412,000 after purchasing an additional 681 shares in the last quarter. Wayfinding Financial LLC purchased a new position in shares of Zoetis in the first quarter valued at $88,000. Finally, Concurrent Investment Advisors LLC grew its position in shares of Zoetis by 20.6% in the first quarter. Concurrent Investment Advisors LLC now owns 17,806 shares of the company’s stock valued at $2,932,000 after purchasing an additional 3,041 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on ZTS shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and dropped their price objective for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Argus reissued a “buy” rating and set a $190.00 price objective on shares of Zoetis in a research note on Tuesday, September 9th. Piper Sandler lifted their price target on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Finally, Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Four research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $195.00.

Zoetis Stock Up 0.1%

ZTS stock opened at $144.25 on Monday. Zoetis Inc. has a fifty-two week low of $139.34 and a fifty-two week high of $183.11. The business’s 50 day moving average price is $147.15 and its two-hundred day moving average price is $153.44. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The company has a market capitalization of $63.93 billion, a price-to-earnings ratio of 24.83, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.14. The company had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis’s dividend payout ratio (DPR) is currently 34.42%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.